These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16890860)

  • 41. Should all patients with peripheral arterial disease be treated with an angiotensin-converting enzyme inhibitor?
    Al-Omran M; Lindsay TF
    Can J Cardiol; 2005 Feb; 21(2):189-93. PubMed ID: 15729421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of cardiovascular risk factors and drug use in 14,544 French patients with a history of myocardial infarction, ischaemic stroke and/or peripheral arterial disease.
    Bongard V; Cambou JP; Lezorovcz A; Ferrères J; Vahanan A; Jullen G; Coppe G; Guerllot M; Herrmann MA; Mas JL
    Eur J Cardiovasc Prev Rehabil; 2004 Oct; 11(5):394-402. PubMed ID: 15616412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Medical treatment of patients with clinical peripheral arterial disease at hospital discharge: compliance with the French guidelines and changing practices (COPART I registry)].
    Béraut E; Cambou JP; Guilhem JM; Vaysse N; Labro S; Séverac D; Boccalon H; Bura-Rivière A
    J Mal Vasc; 2008 Feb; 33(1):1-11. PubMed ID: 18187280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A critical review of antiplatelet treatment in peripheral arterial disease.
    Violi F; Hiatt W
    Intern Emerg Med; 2007 Jun; 2(2):84-7. PubMed ID: 17634816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cardiovascular prevention with peripheral artery disease].
    Vértes A
    Orv Hetil; 2007 Jul; 148(28):1303-9. PubMed ID: 17611180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic antiatherosclerotic treatment for the peripheral arterial occlusive disease patient.
    Baumgartner I
    Expert Opin Pharmacother; 2005 Oct; 6(13):2181-92. PubMed ID: 16218880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic.
    Ness J; Aronow WS; Newkirk E; McDanel D
    J Gerontol A Biol Sci Med Sci; 2005 Feb; 60(2):255-7. PubMed ID: 15814871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
    Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G
    Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality.
    Henke PK; Blackburn S; Proctor MC; Stevens J; Mukherjee D; Rajagopalin S; Upchurch GR; Stanley JC; Eagle KA
    J Vasc Surg; 2004 Feb; 39(2):357-65. PubMed ID: 14743136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD).
    Shigematsu H; Nishibe T; Obitsu Y; Matsuzaki K; Ishida A; Miyata T; Shindo S; Hida K; Ohta T; Ando M; Kawasaki T; Yasugi T; Matsumoto T
    Int Angiol; 2010 Apr; 29(2 Suppl):2-13. PubMed ID: 20357743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Peripheral arterial disease: Treatment].
    Desormais I; Aboyans V; Pesteil F; Lacroix P
    Presse Med; 2018 Jan; 47(1):56-61. PubMed ID: 29273182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A cluster randomized trial to assess the impact of opinion leader endorsed evidence summaries on improving quality of prescribing for patients with chronic cardiovascular disease: rationale and design [ISRCTN26365328].
    Majumdar SR; McAlister FA; Tsuyuki RT
    BMC Cardiovasc Disord; 2005 Jun; 5(1):17. PubMed ID: 15982421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Office management of peripheral arterial disease.
    Aronow WS
    Am J Med; 2010 Sep; 123(9):790-2. PubMed ID: 20800143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Management of the cardiology patient with polyvascular disease: PRISMA study].
    Cournot M; Cambou JP; Ferrières J; Grenier O; Herrmann MA; Cantet C; Leizorovicz A
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):841-8. PubMed ID: 15521475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey.
    McDermott MM; Hahn EA; Greenland P; Cella D; Ockene JK; Brogan D; Pearce WH; Hirsch AT; Hanley K; Odom L; Khan S; Criqui MH; Lipsky MS; Hudgens S
    J Gen Intern Med; 2002 Dec; 17(12):895-904. PubMed ID: 12472925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study of practices: What do general practitioners first propose when faced with asymptomatic lower extremity peripheral artery disease?].
    Rochoy M; Baran J; Doublali A; Berkhout C; Favre J; Descamps A
    Ann Cardiol Angeiol (Paris); 2020 Apr; 69(2):55-59. PubMed ID: 32241521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Anand SS; Bosch J; Eikelboom JW; Connolly SJ; Diaz R; Widimsky P; Aboyans V; Alings M; Kakkar AK; Keltai K; Maggioni AP; Lewis BS; Störk S; Zhu J; Lopez-Jaramillo P; O'Donnell M; Commerford PJ; Vinereanu D; Pogosova N; Ryden L; Fox KAA; Bhatt DL; Misselwitz F; Varigos JD; Vanassche T; Avezum AA; Chen E; Branch K; Leong DP; Bangdiwala SI; Hart RG; Yusuf S;
    Lancet; 2018 Jan; 391(10117):219-229. PubMed ID: 29132880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reduction.
    Hirsch AT; Gotto AM
    Vasc Med; 2002; 7(4):323-31. PubMed ID: 12710848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal function impairment in peripheral arterial disease: an important parameter that should not be neglected.
    Paraskevas KI; Giannoukas AD; Mikhailidis DP
    Ann Vasc Surg; 2009; 23(5):690-9. PubMed ID: 19747617
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.